Dr. Kipps descriptions of chemokines being like our nose being drawn to a Thanksgiving dinner is an analogy that even a vegan can love.
My blog: bkoffman.blogspot.com has the second segment of the ASH2012 interview, mostly on the new BCR inhibitors
ASH 2012, Dr Kipps on BCR inhibitors - CLL Support
ASH 2012, Dr Kipps on BCR inhibitors
Written by
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
2 Replies
•
Hi keep the videos coming as they offer an insight to whats new. Best wishes
bkoffmanCLL CURE Hero
I just published part 3 which is a wide ranging section of the interview covering antibodies, CAR-T, old drugs repurposed, and more. Kipps is an excellent teacher. See: bkoffman.blogspot.com
Not what you're looking for?
You may also like...
ASH 2018: Dr. Kipps on antibodies and Venetoclax resistance
continue to work. In the first part of my interview with Dr. Kipps at ASH 2018, he discusses...
ASH 2016: Dr. Mato on real world data on ibrutinib
clinical trials. You can view my summary, watch the interview or read the transcript here:...
A Conversation with Dr Tam about Zanubrutinib: A Novel BTK Inhibitor
pharmacokinetics and target occupancy?
Zanubrutinib has a more-specific target binding profile than...
ASH 2017: Dr. Richard Furman on the importance of MCL-1 in CLL (chronic lymphocytic leukemia)
Just watched a video on MCL-1 and thought our group might be interested (if not already aware!)....
Acalabrutinib & Proton Pump Inhibitors
Do btk inhibitors kill neurophils?
Imbruvica ibrutinib & ACE inhibitors
